Cardiac Science Gains Home-Use Defibrillator Technology Via Cadent Medical
This article was originally published in The Gray Sheet
Executive Summary
Cardiac Science has acquired automatic external cardiac defibrillator technology intended for home-use to complement the firm's existing hospital-use defibrillator technology through the purchase of privately held Cadent Medical, announced July 6.
You may also be interested in...
Cardiac Science May Pursue Hostile Bid For Spacelabs Installed Monitor Base
Spacelabs Medical's deferring of a decision on Cardiac Science, Inc.' s (CSI) second merger offer in two weeks could lead to a hostile takeover bid to acquire Spacelabs' installed base of about 65,000 hospital patient monitors.
Cardiac Science May Pursue Hostile Bid For Spacelabs Installed Monitor Base
Spacelabs Medical's deferring of a decision on Cardiac Science, Inc.' s (CSI) second merger offer in two weeks could lead to a hostile takeover bid to acquire Spacelabs' installed base of about 65,000 hospital patient monitors.
Cardiac Science
Maker of the Powerheart automatic external cardiac defibrillator-monitor raises $9.7 mil. through a private placement of about 2.2 mil. shares of common stock at $4.50 per share to Swiss investors. Proceeds will be used for global marketing initiatives for the Powerheart, which gained 510(k) clearance in January, as well as for development of additional products and working capital. The Irvine, California company says it is in discussions "with several other investor groups and anticipates additional subscriptions to the current private placement round prior to its closing." Separately, Cardiac Science announces June 27 a license agreement with Medtronic Physio-Control for use of its proprietary technology in Medtronic Physio-Control's LifePak external defibrillators for the hospital market